Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
公司代碼FTRE
公司名稱Fortrea Holdings Inc
上市日期Jun 16, 2023
CEOThakrala (Anshul)
員工數量15500
證券類型Ordinary Share
年結日Jun 16
公司地址8 Moore Drive
城市DURHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編27709
電話18774950816
網址https://www.fortrea.com/
公司代碼FTRE
上市日期Jun 16, 2023
CEOThakrala (Anshul)